These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35348774)
1. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis. Sonbol MB; Mazza GL; Mi L; Oliver T; Starr J; Gudmundsdottir H; Cleary SP; Hobday T; Halfdanarson TR Oncologist; 2022 Jul; 27(7):573-578. PubMed ID: 35348774 [TBL] [Abstract][Full Text] [Related]
2. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. Liu X; Chen B; Chen J; Su Z; Sun S J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587 [TBL] [Abstract][Full Text] [Related]
3. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors. Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797 [TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors. Shi M; Zhou B Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476 [TBL] [Abstract][Full Text] [Related]
5. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment. Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484 [TBL] [Abstract][Full Text] [Related]
6. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Kuo EJ; Salem RR Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study. Yadav S; Sharma P; Zakalik D Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698 [TBL] [Abstract][Full Text] [Related]
9. The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis. Wang S; Zhang J; Liu S; Zhang J Medicine (Baltimore); 2019 Nov; 98(44):e17773. PubMed ID: 31689842 [TBL] [Abstract][Full Text] [Related]
10. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database. Zhai H; Li D; Feng Q; Qian X; Li L; Yao J Int J Surg; 2019 Jun; 66():103-109. PubMed ID: 30872175 [TBL] [Abstract][Full Text] [Related]
12. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study. Lin J; Huang H Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors of Small Non-Functional Pancreatic Neuroendocrine Tumors and the Risk of Lymph Node Metastasis: A Population-Level Study. Tan Q; Wang X; Li Y; Liu Y; Liu X; Ke N Front Endocrinol (Lausanne); 2022; 13():907415. PubMed ID: 35873006 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis. Mei W; Cao F; Lu J; Qu C; Fang Z; Li J; Li F Front Endocrinol (Lausanne); 2023; 14():1140873. PubMed ID: 37020595 [TBL] [Abstract][Full Text] [Related]
16. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384 [TBL] [Abstract][Full Text] [Related]
17. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality. Wu J; Sun C; Li E; Wang J; He X; Yuan R; Yi C; Liao W; Wu L BMC Cancer; 2019 Apr; 19(1):334. PubMed ID: 30961556 [TBL] [Abstract][Full Text] [Related]
18. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation. Chen J; Yang Y; Liu Y; Kan H World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017 [TBL] [Abstract][Full Text] [Related]
19. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study. Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417 [TBL] [Abstract][Full Text] [Related]
20. The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database. Wu Z; Qiu X; Zhi Y; Shi X; Lv G Front Oncol; 2022; 12():993524. PubMed ID: 36276109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]